Veil Preserving HoLEP vs. Stanadard HoLEP (MansprostIV)

June 13, 2023 updated by: Ahmed Elshal, Mansoura University

Veil-preserving Versus Standard Holmium Laser Enucleation of the Prostate: Randomized Clinical Trial

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Our hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if anny would be shortened.

Study Overview

Detailed Description

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients.

Many reports addressed different variables for the cause of post HoLEP urine leakage. Looking for a procedure done by a single surgeon who had tremendous experience of this procedure may enable investigators to identify precisely technical points of interest that may affect post HoLEP stress urine incontinence.

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Investigators' hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if any would be shortened.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DK
      • Mansoura, DK, Egypt, 35516
        • Urology and nephrology center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients' age ≥50 years
  2. ASA (American society of anesthesiologists) score ≤3.
  3. TRUS estimated weight ≥40 grams.

Exclusion criteria:

Patients who have any of the following were excluded:

  1. Patient with neurological disorder which might affect bladder function as cerebrovascular stroke or Parkinson disease.
  2. Active urinary tract infection.
  3. Presence of bladder cancer (within the last 2 years).
  4. Prostate cancer patients.
  5. Patients with bleeding tendency, ongoing anticoagulants or antiplatelet medications
  6. Previous prostate surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Veil sparring HoLEP

Early mucosal incision lateral to the Veru followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch.

Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Early mucosal incision; lateral to the Veru and proximal to the apical bulge of the adenoma, followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch.

Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Other Names:
  • early apical separation
Active Comparator: Standard HoLEP
Standard HoLEP TECHNIQUE as described by Elhilali et al 2010
Holmium laser enucleation of the prostate in the standard approach described by Elhilali et al 2010

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
urine incontinence
Time Frame: 1 month postoperative
one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence
1 month postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
international prostate symptom score
Time Frame: 1 year
Symptoms core assessment, score from 0 to 35, the higher the worse the urinary symptoms
1 year
urine flow rate
Time Frame: 1 year
rate of urine flow per unit time, how many milliliters of urine passed per second, above 15ml/second is normal
1 year
urine incontinence
Time Frame: 4 months postoperative
one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence
4 months postoperative
International Consultation on Incontinence Questionnaire Short-Form
Time Frame: one month postoperative
Continence core assessment, score from 0 to 21, the higher the worse the urinary continence
one month postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ahmed Elshal, Mansoura University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2016

Primary Completion (Actual)

December 8, 2020

Study Completion (Actual)

December 12, 2021

Study Registration Dates

First Submitted

March 31, 2018

First Submitted That Met QC Criteria

April 10, 2018

First Posted (Actual)

April 11, 2018

Study Record Updates

Last Update Posted (Actual)

June 15, 2023

Last Update Submitted That Met QC Criteria

June 13, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • RP.19.11.49

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Prostatectomy Incontinence

Clinical Trials on Veil sparring HoLEP

Subscribe